First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
★ Analysts see FY2026 revenue reaching $139M — -0.3% growth in a single year.
What Moves the Stock
1Paging subscriber unit churn rate: Quarterly net subscriber losses exceeding 3-4% trigger valuation compression as investors extrapolate terminal value concerns
2Software revenue growth trajectory: Any acceleration in Spok Care Connect adoption signals successful business model transition and commands premium multiples
3Capital allocation announcements: Special dividends or share buyback authorizations drive near-term price appreciation given high FCF conversion
4Healthcare IT spending trends: Hospital capital expenditure cycles for clinical communication infrastructure upgrades directly impact software segment bookings
5Wireless paging services (~65-70% of revenue): One-way pager subscriptions and related equipment sales to healthcare facilities
6Software and healthcare communication services (~25-30%): Spok Care Connect and clinical alerting platforms for secure messaging
7Professional services and maintenance (~5-10%): Implementation, training, and ongoing technical support
value - The stock attracts deep value investors focused on high FCF yields (9.2%) and potential for return of capital through dividends…
Rising interest rates create modest headwinds through two channels: (1) Higher discount rates compress valuation multiples for declining…
Watch on earnings: Quarterly paging subscriber unit count and net change (disclosed in 10-Q filings), Software segment revenue growth rate and percentage of total revenue mix, Healthcare IT capital expenditure trends (AHA annual survey data, vendor earnings commentary).
One Sentence Summary:
Spok: the story is balanced — paging subscriber unit churn rate: quarterly net subscriber losses exceeding 3-4% trigger valuation compression as investors extrapolate.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.